The OncoTarget project includes manufacture of drugs of the most commonly demanded nosological groups in order to carry out state import substitution policy and is designed to arrange for the manufacture of drugs that are not currently produced in the Russian Federation.
The Company's product portfolio includes about 30 types of drugs in various dosage forms planned for manufacture by the end of 2022; these drugs are used to treat oncological, neurological, endocrinological and other high-profile diseases.
Company Details
- Employees
- 2
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://oncotarget.pro/
- Keywords
- Yerevan.
Oncotarget Questions
Oncotarget's website is https://oncotarget.pro/
Oncotarget's LinkedIn profile is https://www.linkedin.com/company/%D0%BE%D0%BD%D0%BA%D0%BE%D1%82%D0%B0%D1%80%D0%B3%D0%B5%D1%82
Oncotarget has
2 employees.
View email and phone details for 2
employees at Oncotarget.
Oncotarget's industry is
Pharmaceutical Manufacturing
Oncotarget's top competitors are
Fortrea,
Control Print,
Sun Pharma,
Ingal,
Crocus Medical B.v. (The Netherlands),
Thermo Fisher Scientific,
Jenguro,
Horus Co Ltd,
Axelpharm.
Oncotarget's categories are Pharmaceutical Manufacturing
